Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
3.550
-0.030 (-0.84%)
May 12, 2025, 4:00 PM - Market closed
Biomerica Market Cap
Biomerica has a market cap or net worth of $9.04 million as of May 13, 2025. Its market cap has decreased by -24.69% in one year.
Market Cap
9.04M
Enterprise Value
6.52M
1-Year Change
-24.69%
Ranking
Category
Stock Price
$3.55
Market Cap Chart
Since August 29, 2016, Biomerica's market cap has decreased from $24.30M to $9.04M, a decrease of -62.81%. That is a compound annual growth rate of -10.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 9.10M | 82.00% |
| Dec 31, 2024 | 5.00M | -76.19% |
| Dec 29, 2023 | 21.00M | -53.33% |
| Dec 30, 2022 | 45.00M | -7.60% |
| Dec 31, 2021 | 48.70M | -16.75% |
| Dec 31, 2020 | 58.50M | 96.97% |
| Dec 31, 2019 | 29.70M | 92.86% |
| Dec 31, 2018 | 15.40M | -51.72% |
| Dec 29, 2017 | 31.90M | 69.68% |
| Dec 30, 2016 | 18.80M | -22.63% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |